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Abstract: Phobias are common in later life, yet treatment research in this population remains 
scant. The effi cacy of exposure therapy, in combination with other Cognitive-Behavioral Therapy 
(CBT) components, in the treatment of specifi c phobia with a middle and older aged sample 
was examined. Sixteen adults aged 45–68 with DSM-IV diagnosis of a specifi c phobia received 
a manualized intervention over ten weeks, and were compared with a control group. Results 
indicated signifi cant time effects in the treatment group for the primary outcome variables of 
phobic severity and avoidance as well as secondary outcome variables including depression 
and anxiety. Symptom presence and severity also signifi cantly declined in the treatment group. 
No signifi cant changes in state anxiety were noted across the treatment period. Such results 
provide support for the effi cacy of exposure combined with CBT treatment for specifi c phobia 
in middle to older aged adults.
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Introduction
Anxiety disorders in older adults have received relatively little empirical attention in the 
treatment literature. Although most current prevalence estimates suggest that anxiety 
disorders later in life may be less frequent, high relative prevalence rates for anxiety 
compared to other mental disorders and the signifi cant negative impact of anxiety on 
the lives of older people argue for its importance. Anxiety disorders have been found 
to be twice as frequent as affective disorders, and 4–8 times more frequent than major 
depressive disorders, in older samples (Beck and Stanley 1997). These disorders have 
also been reported to be more prevalent than depression or severe cognitive impair-
ment among older adults (Regier et al 1988).
Anxiety symptoms are associated with reduced quality of life, increased mortality, 
impaired ability to carry out Instrumental Activities of Daily Living (IADLs), poorer 
health, more chronic illness, and elevated levels of reported pain in older cohorts 
(reviewed in Scogin et al 2000). Findings that older people with phobic or panic 
disorders have higher relative risk of ischemic heart disease, stroke, and death by 
suicide indicate that anxiety disorders may be associated with greater morbidity and 
mortality, underscoring the importance of addressing anxiety issues in this population 
(Krasucki et al 1998; Stanley and Beck 2000). Finally, older adults have been found 
to experience symptoms of anxiety disruptive enough to require intervention, even 
if insuffi cient to warrant formal diagnosis (Himmelfarb and Murrell 1984). Indeed, 
Schaub and Linden (2000) suggest that while the contribution of anxiety to the spec-
trum of mental disorders seems to decrease with age, anxiety symptoms are an almost 
daily experience for many older people.
Specifi c phobias in older adults
Findings are inconsistent with respect to the relative prevalence of various anxiety 
disorders in older cohorts. Several studies have reported phobias to be the most com-
mon anxiety disorder among older people (eg, Regier et al 1988), whereas others 
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have not (eg, Bland et al 1988). Earlier studies including 
GAD among the diagnoses reported phobias as less common 
than GAD (Uhlenhuth et al 1983; Copeland, Dewey et al 
1987; Copeland, Gurland et al 1987). However, more recent 
research by Ritchie et al. (2004) found phobias to be the 
most common anxiety disorder in their sample of community 
dwelling older adults, with lifetime prevalence rates of 21.6% 
and 11% currently experiencing phobias; in contrast, lifetime 
prevalence of GAD was estimated to be 10.8%, while current 
prevalence rates were estimated at 4.6%.
The overall prevalence of specifi c phobias as well as their 
prevalence relative to other phobia subtypes in later life is 
also somewhat unclear. The highest prevalence rates have 
been found by Lindesay, Briggs and Murphy (1989), who 
report a 10.0% phobia prevalence rate among people 65 years 
of age and older, with agoraphobia accounting for 7.8% of 
this total, while specifi c phobia and social phobia represent 
2.1% and 1.3% respectively. Fear of spiders and insects 
were the most common form of specifi c phobia in the age 
65+ sample, accounting for 33.3% of the phobic fears. This 
was followed (in order) by cats/dogs (27.7%); blood/injury 
(5.6%), and heights (5.6%); with 27.7% of the phobic sample 
reporting other specifi c fears. Lindesay (1991) supported 
these fi ndings, reporting that animals, heights and enclosed 
spaces were the most common fears, noting that these are 
similar to those identifi ed in previous research among a 
general adult population as ‘long-lived’ phobias.
Treatment of anxiety in older 
populations
Although investigation of effective ways to address anxiety 
in this population is critical, treatment research has remained 
scant. Most research in this area has primarily focused on 
older people with anxiety symptoms rather than diagnoses 
(eg, De Berry et al 1989; Scogin et al 1992); uncontrolled 
clinical case reports (eg, Thyer 1981; Rowan et al 1984) 
and treatment studies lacking a no treatment control condi-
tion (eg, King and Barrowclough 1991; Stanley, Beck and 
Glassco 1996). The existing research base has provided 
some evidence of the utility of CBT for self-report anxi-
ety symptoms in community samples of older people (see 
McCarthy et al 1991; Hersen and van Hasselt 1992) how-
ever well-controlled research investigating the effi cacy of 
established treatments in clinical samples over the age of 
50 remains sparse.
Perhaps the most controlled and comprehensive study 
in the area of late-life anxiety is that conducted by Stanley 
et al (2003) investigating the effi cacy of CBT for late-life 
GAD. Stanley et al recruited 85 adults aged 60 years and over 
through media announcements. Results indicated signifi cant 
improvement in self-report and clinician rated measures 
of worry, anxiety, depression and quality of life following 
CBT compared to Minimal Contact Control (MCC), with 
45% of those in the CBT condition classifi ed as ‘treatment 
responders.’
Despite evidence that phobic disorders are one of the most 
common anxiety diagnoses among this population group 
(Ritchie et al 2004) and are one of the easiest to treat among 
younger samples (Antony and Barlow 1998), they have 
remained almost unstudied in older populations, with case 
studies (eg, Thyer 1981) lending only limited understanding 
of treatment effi cacies in this age group.
The current study aims to extent existing treatment pro-
tocols, including exposure therapy components, for specifi c 
phobias to a sample of older adults in order to assess the 
effi cacy of such techniques among this population. The 
impact of age upon outcome is also of interest, and inclusion 
of a middle aged and older sample will allow comparison of 
treatment effect on the basis of the age variable.
Method
Participants
Treatment group sample
The treatment group consisted of 16 subjects between 45 
and 68 years of age, with a mean age of 55 years. The group 
consisted of 3 males and 13 females. Although this clearly 
represents a signifi cant difference across gender, this was 
expected given that research has suggested that phobias 
are much more common in women than men (eg, Arnarson 
et al 1998). Recruitment was through media releases regard-
ing the project, fl yers sent to local general practitioners, and 
recruitment from a community database of older volunteers 
(N = 150).
All treatment group participants had a Diagnostic and 
Statistical Manual of Mental Disorders (4th edition, DSM-IV; 
American Psychological Association [APA], 1994) diagnosis 
of Specifi c Phobia, as confi rmed by administration of the 
Structured Clinical Interview for the DSM-IV (SCID-IV; 
First, Spitzer, Gibbon and Williams 1997). In the treatment 
group, 4 of 16 participants had current co-morbid diagnoses, 
including Major Depression, Social Phobia and GAD. In 
terms of inclusion and exclusion criteria, the current study 
has aimed to fi nd a more balanced approach in line with 
recent suggestions in the literature for improved effectiveness 
and generalizability of results (eg, Guthrie 2000). As such, 
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subjects were not excluded if they had current co-morbid 
diagnoses (if such conditions did not require more immedi-
ate treatment), were currently taking anxiety medications 
(as long as dosages remained stable), had a past history 
of alcohol use, did not complete all sessions within the 
designated time periods, or had previously been involved in 
anxiety treatment programs.
Subjects were excluded if they were outside the ages of 
45–75 years of age, had other major psychiatric or cogni-
tive problems requiring immediate treatment, psychotic or 
organic illnesses, major untreated substance abuse, or disease 
of the heart or lungs. People with fl ying phobia, injection 
phobia and blood phobia were also specifi cally excluded 
from this study due to the practical diffi culties with exposure 
techniques for these phobic stimuli.
Approximately 44 people completed phone-screening 
interviews after expressing an interest in the project. Of 
the 28 deemed eligible for participation, 5 declined further 
participation and 23 completed the initial interview and 
were accepted into the program. Of these 23, 4 withdrew 
prior to treatment commencement and 2 withdrew in 
weeks 4 and 5, leaving 16 participants having completed 
treatment.
Control group samples
A ‘wait-list control group’ was formed consisting of fi ve 
participants who had sought treatment randomly allocated 
to a wait-list control group condition. However, time con-
straints of the project and fears over drop-out rates led to 
this group’s relatively small numbers being supplemented 
with a “convenience sample” control group consisting of 
participants recruited from a large postal survey of older 
adults’ attitudes toward mental health treatment. Within the 
mail-out sample (N = 159), a question had been asked of 
participants as to whether they whether they had a phobia and 
if they were interested in treatment. Of the 50 participants 
that indicated they were willing to participate in follow-up 
studies, the fi rst 24 subjects able to be contacted by telephone 
by the researcher were administered the phobia section of 
the SCID-IV and sent questionnaires identical to those given 
to the treatment and wait-list groups outlined above. Of this 
group of 24, 8 participants met criteria for a DSM-IV diag-
nosis of Specifi c Phobia determined by use of the SCID-IV 
as per the treatment group.
Thus the control group consisted of 13 subjects be-
tween 52 and 70 years of age, with a mean age of 59 years. 
The group consisted of 1 male and 12 females. These 
control group participants were then sent an identical 
questionnaire after a period of 10 weeks to assess change 
in variables of interest over this period in an untreated 
sample.
Initial data screening revealed no signifi cant differences 
between treatment and control groups at time one in terms 
of age (F
(1, 27)
 = 0.28, p  0.05), phobic avoidance (F
(1, 27)
 = 
1.58, p  0.05), phobic severity (F
(1, 27)
 = 2.30, p  0.05), or 
anxiety as measured by the GAI (F
(1, 26)
 = 0.25, p  0.05).
Measures
The Mini-Mental Status Exam (MMSE) (Folstein et al 1975) 
was utilized to screen for gross cognitive impairment; par-
ticipants scoring less that 24 were to be excluded from the 
study (none met this criteria).
The Structured Clinical Interview for DSM-IV (SCID-IV) 
(First et al 1997) was used as a ‘gold standard’ of interview 
based assessment measures (Scogin et al 2000).
The Fear Questionnaire (FQ) (Marks and Matthews 
1979) is a self-report measure designed to monitor change 
in patients with phobias. A slightly modifi ed version of the 
FQ was used to measure phobic avoidance, phobic severity 
and anxiety/depression, with questions pertaining to ago-
raphobia, blood/injury and social phobia omitted from the 
adapted version of the FQ.
The Geriatric Depression Scale-15 item (GDS-15) 
(Brink et al 1982), the State-Trait Anxiety Inventory (STAI) 
(Spielberger et al 1970) and the Geriatric Anxiety Inventory 
(Pachana et al 2007) were used to measure depressive and 
anxious symptoms among participants.
The Symptom Checklist-90-Revised (SCL-90-R) 
(Derogatis 1994) is a self-report measure of psychological 
symptom patterns and provide an estimation of current, point-
in-time psychological symptom status (Derogatis 1994). This 
measure has also been used in a number of studies with older 
adults, and has been found to be sensitive to post-treatment 
improvements in general functioning among older people 
(Scogin et al 1992).
Procedure
Screening of subjects was conducted initially via telephone. 
Telephone screening questions addressed specifi c, easily 
identifi ed exclusionary criteria such as phobia type, age, pres-
ent involvement in psychotherapy and presence of serious 
contraindicative medical conditions. Following initial phone 
screening, participants were asked to attend a face-to-face 
interview. This phase included signing of consent forms, 
assessment of the onset and history of their phobic symptoms 
and further assessment of treatment suitability, including the 
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administration of the MMSE and the SCID-IV screening and 
diagnostic instruments.
Subjects passing screening processes were then alter-
nately allocated to one of two conditions: treatment (anxiety 
management training plus exposure therapy) or no-treatment 
wait-list control based on interview date. A single crossover 
approach was employed, whereby those subjects in wait-list 
control groups received treatment subsequent to fi rst round 
completions.
Participants in the treatment group were administered 
questionnaires at the conclusion of the initial group session 
(session one) and following the fi nal individual exposure 
session (session ten). A mid-treatment questionnaire was also 
administered at the conclusion of the fi nal group session (ses-
sion fi ve), which contained the same questionnaires as pre and 
post sessions but omitted the more laborious SCL-90-R.
Treatment approach and rationale
The treatment program involved a total of 10 sessions, 
including 5 group-training sessions initially, followed 
by 5 sessions of individual therapy. Each session (both 
group and individual) was approximately 1.5 hours dura-
tion. Group sessions were conducted in small groups of 
2–7 members. Each group session was facilitated by two 
registered psychologists enrolled in postgraduate studies at 
the University of Queensland. The fi rst author (Woodward) 
facilitated one group with another postgraduate psychologist, 
while the other three groups were run with two postgradu-
ate psychologists. Individual sessions were then conducted 
one-on-one by group therapists, so that each subject had 
previously had contact with their individual therapist during 
group sessions.
A manualized treatment approach was utilized, based 
on the treatment protocols of several authors, including 
Borkovec and Costello (1993); Antony, Craske, and Barlow 
(1995); Craske, Antony and Barlow (1997); Antony and 
Barlow (1998). Each session followed a standard structure, 
commencing with agenda setting, moving to a review of 
key information from the previous session, the past week’s 
achievements and progress with completion of ‘take-home 
tasks’ (homework activities). This was followed by primary 
session content, including either presentation of psycho-
educational material or introduction and practice of a new 
skill. Take-home tasks were then allocated and explained. 
The manuals used in this study are available from the fi rst 
author (Pachana).
Several researchers have suggested minor alterations in 
treatment process that may enhance outcome when working 
with older adults (Koder et al 1996; Hinrichsen and Dick-Siskin 
2000; Garner 2003). Specifi cally, it has been suggested that 
older people may need longer socialization into therapy with a 
greater emphasis on treatment rationale, a slower pace of therapy, 
and greater reliance on the utilization of memory aids and rein-
forcement strategies, such as summaries, handouts, and verbal 
repetition of themes and issues throughout therapy. It has also 
been suggested that older people can be comforted by knowing 
that there is a plan of action that will guide weekly meetings and 
through selection of realistic and concrete goals.
The current treatment approach was designed with the 
above recommendations in mind. The initial group session 
was devoted primarily to socialization to therapy and ‘getting 
to know’ group members, to allow participants some time to 
become accustomed to the treatment process. Early sessions 
were devoted to psychoeducation and a thorough introduction 
to the program, with active session content not introduced 
until session three. During the early sessions, time was 
allowed for group members to discuss how they might have 
acquired their phobia, and discussion of weekly encounters 
with phobic stimulus was maintained throughout all sessions 
to allow a chance for shared experiences and encouragement 
between group members to occur. Throughout the sessions, 
a clear treatment rationale was offered for all techniques. 
Information sheets covering session content were also given 
for most sessions, and each began with a review of the 
previous week’s content and what had been achieved.
In terms of treatment components, it was determined that 
session content should incorporate both in-vivo exposure 
techniques, which have consistently been found to be the cor-
nerstone of phobia treatment, and other treatment components, 
such as psychoeducation, anxiety management and cognitive 
and relaxation procedures. Although evidence for the utility 
of exposure therapy in older adults is currently limited to sev-
eral single-subject case studies (eg, Thyer 1981), consistent 
evidence of strong treatment effects for this technique among 
younger people argues for its inclusion in the current treatment 
approach. Similarly, although the effi cacy of including cogni-
tive and relaxation components in phobia treatment protocols 
has not been fi rmly established, there were salient reasons for 
their inclusion in the current study. Relaxation training, for 
example, has been found to signifi cantly reduce stress-related 
disorders, psychosomatic symptoms, self-reported tension 
levels and state anxiety in older people (De Berry 1982; 
De Berry et al 1989; Scogin et al 1992). Finally, studies 
utilizing cognitive techniques for both anxiety (King and 
Barrowclough 1991) and depression (Koder et al 1996) have 
been found to be effective in older populations.
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Results
Attrition
Of the 19 clinical participants that commenced the treatment 
program, 16 completed the total of 10 sessions. Of these, 
12 completed within a two-week window of the 10 weeks 
allocated, while 4 took longer to complete due to cancella-
tions or personal circumstances. It should be noted, however 
that all 16 clinical participants completed the same number of 
sessions, of the same approximate duration. All 13 wait-list 
controls completed initial and follow-up questionnaires.
Changes over time within the treatment 
group
Analysis indicated a signifi cant effect of time on avoidance of 
phobic stimuli (χ2 = 20.348, df = 2, p  0.0001) as measured 
by the avoidance scale of the FQ. Posthoc analysis revealed 
signifi cantly lower avoidance levels at time three than at 
time one (z = –3.194, N-Ties = 13, p = 0.001, two-tailed) 
and at time three than at time two (z = –3.082, N-Ties = 13, 
p = 0.002, two-tailed). There was not, however, a signifi cant 
difference between mean avoidance at time one compared 
with time two (z = 1.983, N-Ties = 7, p = 0.057, two-tailed). 
Mean scores on all outcome measures are included in Table 1.
Analysis also indicated a signifi cant effect of time on 
severity of phobic symptoms (χ2 = 19.172, df = 2, p  0.001) 
as measured by the severity scale of the FQ. Similar to phobic 
avoidance described above, posthoc analysis revealed signifi -
cantly lower phobia severity at time three compared with time 
one (z = –3.527, N-Ties = 16, p = 0.000, two-tailed) and at 
time three compared with time two (z = –2.810, N-Ties = 14, 
p = 0.005, two-tailed). Once again, there was no signifi cant 
difference between phobic severities at time two compared 
to time one (z = –1.339, N-Ties = 12, p = 0.181).
Results from the Anxiety-Depression scale of FQ also 
revealed a signifi cant effect of time (χ2 = 13.508, df = 2, p 
 0.005). Posthoc analysis revealed signifi cant differences 
between all time points. More specifi cally, anxiety-depression 
was significantly lower at time two than at time one 
(z = –2.390, N-Ties = 15, p = 0.017, two-tailed), signifi cantly 
lower at time three than at time one (z = –3.154, N-Ties = 
15, p = 0.002, two-tailed) and signifi cantly lower at three 
compared to time two (z = –2.736, N-Ties = 15, p = 0.006, 
two-tailed).
Results from the GAI also indicated a signifi cant effect 
of time on anxiety levels (χ2 = 14.452, df = 2, p  0.005). 
Posthoc analysis revealed a slightly different pattern of 
results, however, with signifi cant reductions in anxiety 
found between time one and time two (z = –3.301, N-Ties 
= 14, p = 0.001, two-tailed) and between time one and time 
three (z = –3.157, N-Ties = 16, p = 0.002, two-tailed), but 
no signifi cant reduction in anxiety between time two and 
time three (z = –1.581, N-Ties = 16, p = 0.114, two-tailed).
While results did not refl ect a signifi cant effect of time on 
state anxiety (χ2 = 0.603, df = 2, p0.05), trait anxiety levels 
did exhibit signifi cant changes over time (χ2 = 12.000, df = 2, 
p  0.05). Posthoc analysis revealed that, similar to anxiety 
measured via the GAI, there were signifi cant reduction in 
trait anxiety between time one and time two (z = –3.134, 
N-Ties = 16, p = 0.002, two-tailed) and between time one and 
time three (z = –3.136, N-Ties = 16, p = 0.002, two-tailed), 
however; there was no signifi cant reduction in trait anxiety 
levels between time two and time three (z = –0.566, N-Ties 
= 14, p = 0.572, two-tailed).
Analysis revealed a signifi cant effect of time upon depres-
sion levels, as measured by the GDS-15 (χ2 = 12.792, df = 2, 
p  0.005). Posthoc analysis revealed signifi cant reductions 
in depression between time one and time three (z = –2.956, 
N-Ties = 9, p = 0.003, two-tailed), and between time one and 
time two (z = –2.071, N-Ties = 9, p = 0.038, two-tailed) but 
no signifi cant reduction in depression between time two and 
time three (z = –1.082, N-Ties = 12, p = 0.279, two-tailed).
Analysis revealed signifi cant reductions in symptoms 
on the three global indexes of the SCL-90-R between time 
one and time three, including the global symptom index 
(χ2 = 4.571, df = 1, p  0.05), the positive symptom distress 
index (χ2 = 6.231, df = 1, p  0.05) and the positive symptom 
total (χ2 = 4.571, df = 1, p  0.05). The SCL-90-R was not 
administered at time two, and thus comparisons between 
mid-point time periods are not possible.
Comparisons between treatment and 
control groups
Group differences were analyzed using a time (2) x group 
(2) mixed between and within participants Analyses of 
Variance (ANOVA). Although violations of the assump-
tions of parametric statistical procedures suggested that 
non-parametric analysis would, in this instance, be a more 
appropriate indicator of treatment outcome, a lack of non-
parametric alternatives to the ANOVA meant that parametric 
options were necessary. It should be noted, however, that 
such procedures are at best exploratory and the reliability of 
the results signifi cantly limited by such violations.
Results indicated signifi cant interactions between time (2) 
and group (2) for phobic avoidance (F
(1,27) 
= 24.50, p  0.05), 
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phobic severity (F
(1, 27)
 = 66.15, p  0.05), and anxiety as 
measured by the GAI (F
(1, 26)
 = 24.91, p  0.05). This sug-
gests that the impact of time on outcome variables differed 
between treatment groups.
Post-hoc pair-wise comparisons between time one and 
time three scores for the control group were conducted us-
ing the non-parametric Wilcoxin Signed Ranks Test due to 
the normality assumption violations mentioned above. This 
revealed no signifi cant differences between time one and 
time three for phobia avoidance (z = –0.073, N-Ties = 5, 
p = 0.942, two-tailed), or phobia severity (z = –1.725, N-
Ties = 5, p = 0.084, two-tailed). Signifi cant differences in 
anxiety, as measured by the GAI, were found between time 
one to time three (z = –2.194, N-Ties = 3, p = 0.028, two-
tailed), however means revealed that unlike the reductions 
in anxiety noted for the treatment group sample, anxiety was 
higher at time three (X = 23.15) than at time one (X = 19.67) 
in the control group.
These results confi rm that unlike the signifi cant reduc-
tions in the treatment group in phobic avoidance, phobic 
severity and anxiety as measured by the GAI across time (as 
noted above), there were no signifi cant changes on phobic 
avoidance or severity across time, and a signifi cant increase 
in general anxiety from time one to time three, for the control 
group sample.
Discussion
The current study has demonstrated the potential benefi cial 
effects of a CBT-based program for the treatment of spe-
cifi c phobias in a small sample of mid to older aged adults. 
Although past research has supported the extension of 
established treatment protocols for other anxiety symptoms 
and disorders to older people, none have examined the treat-
ment of specifi c phobias among older populations. Among 
the treatment group of the current sample, improvements 
were noted post-treatment on almost all outcome variables, 
including phobia avoidance, phobia severity, anxiety (as 
measured by the anxiety-depression scale of the FQ, the GAI 
and STAI-Trait), depression and overall symptom presence 
and severity. Interestingly, state anxiety did not exhibit sig-
nifi cant reductions across the treatment period.
Past research has demonstrated the positive therapeutic 
effects of exposure therapy in individual older adults with 
specifi c phobias and obsessive compulsive disorder (Thyer 
1981; Rowan et al 1984; Calamari et al 1994), the benefi ts 
of relaxation and cognitive techniques among older people 
with general anxiety complaints (De Berry et al 1989; Scogin 
et al 1992), and the effi cacy of CBT techniques with older 
people diagnosed with GAD (King and Barrowclough 1991; 
Stanley, Beck and Zebb 1996; Stanley et al 2003). The current 
research is, however, the fi rst study to demonstrate effi cacy of 
established treatment protocols for mid-age and older adults 
with diagnosed specifi c phobias.
Findings regarding reductions in phobic avoidance and 
severity are in line with past treatment research among 
younger samples, which have consistently reported strong 
treatment effects for exposure-based treatment of specifi c 
phobias (Antony and Barlow 1998). Past research has also 
supported the differences found between treatment and 
control conditions in the current study (Antony and Barlow 
1998), although as noted such conclusions must be drawn 
with caution due to problems with control group condi-
tions.
Such results suggest that exposure therapy is an effec-
tive treatment among mid-aged to older adults, and can 
be extended to older cohorts with minimal changes to the 
treatment approach. Exposure sessions were not of longer 
duration, nor of greater frequency, than those reported 
among younger samples, and were similar to treatment 
duration previously reported for exposure treatment among 
single-subject studies of older people (Thyer 1981; Rowan 
et al 1984). Despite claims that exposure therapy may not 
be appropriate among older people (McCarthy et al 1991), 
this study supports past suggestions from single case studies 
that anxiety was well tolerated and does not interfere with 
the course of therapy (Thyer 1981) and requires only minor 
modifi cations for older subjects (Calamari et al 1994).
Although the current study included additional treat-
ment components of psychoeducation, relaxation and 
cognitive therapy components, it is uncertain if such 
components were necessary for treatment outcome. Future 
research into the relative efficacy of exposure treatments 
both with and without additional components would be 
of great value.
It is a somewhat curious fi nding that while signifi cant 
reductions in trait anxiety were found, state anxiety did not 
differ signifi cantly across the treatment period in the treat-
ment group. Such fi ndings are in contrast to past fi ndings 
in the anxiety treatment literature among older populations. 
De Berry et al. (1989), for example, found that ‘relaxation-
meditation’ treatment signifi cantly decreased levels of state 
anxiety, but was not effective in reducing trait anxiety. 
Similarly, Scogin et al. (1992) found a reduction in state 
anxiety and self-reported personal adjustment, but not trait 
anxiety, post-treatment for both progressive and imaginal 
relaxation conditions.
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Such results are perhaps not unexpected, however, 
given that both of the above investigations focused more 
specifi cally on relaxation techniques in the context of general 
anxiety complaints. Logically, a treatment protocol involv-
ing exposure therapy would have less impact on current 
anxiety levels than one that promotes relaxation. Indeed, 
Scogin et al (1992) found that despite pre to post-treatment 
reductions in state anxiety, such improvements were not 
maintained at follow-up, suggesting that decreases in state 
anxiety might have resulted from relaxation procedures 
immediately proceeding administration of assessment 
measures, rather than more pervasive effects.
Significant mid- and post-treatment reductions in 
depression are also in line with past research investigating 
the treatment of anxiety among older people, with many 
studies finding significant improvements in depression 
following anxiety treatment programs. Stanley, Beck and 
Glassco (1996), for example, found signifi cant reductions in 
depression among a group of older subjects with diagnosed 
GAD following a 14-week group CBT program. Similarly, 
Stanley et al (2003) found signifi cant improvements in both 
depression and quality of life following CBT treatment of 
late-life GAD. Reductions in all three global measures of 
the SCL-90-R are also encouraging, and suggest that both 
general symptom presence and severity decreased following 
treatment.
The fi nding that treatment improvements extend beyond 
phobic symptomatology and general anxiety levels to other 
psychological variables, such as depression and general 
symptom presence and severity, is particularly encouraging. 
It argues for broader treatment effects for a disorder both 
common in this age group and often left untreated. Indeed, 
the fact that general symptom improvements are in line with 
fi ndings from more ‘pervasive’ disorders such as Generalized 
Anxiety Disorder (GAD), suggest that treatment of phobias 
may have positive benefi ts beyond the obvious and argues 
strongly for the importance of addressing specifi c phobias 
among this age group.
The signifi cant differences between the treatment and con-
trol group again highlights the effi cacy of this treatment among 
our small sample; however, it should be noted that this small 
sample size severely limits generalization, and further studies 
with more robust sample sizes should be attempted.
Although diffi culties with the control group characteris-
tics limit conclusions, the control group data does suggest 
that among a sample of older people, phobic severity and 
avoidance does not signifi cantly change over a period of 10 
weeks if untreated. This suggests that, despite the limitations 
of this control group data, it is perhaps unlikely that the treat-
ment improvements are due to random factors alone. Such a 
conclusion, however, warrants further empirical validation 
before it can be claimed with confi dence.
Overall, the results of the current study suggest that 
exposure-based treatment of specifi c phobias has potential 
clinical utility in an older sample of people than those previ-
ously utilized in phobia research. Mid-aged and older aged 
adults with specifi c phobias may experience improvements 
in both their phobic symptoms as well as associated symp-
tomatology, including general anxiety and depression, fol-
lowing treatment. Although the recruitment diffi culties that 
plague research attempts with older populations signifi cantly 
impacted on both the strength and breadth of conclusions in 
the current instance, if current fi ndings are extended by fur-
ther research they have the potential to signifi cantly impact 
on the treatment approach for older phobics. Exposure has 
consistently exhibited the strongest treatment effects of any 
psychological treatment approach. Findings in support of its 
utility with older people may serve to reduce the reluctance 
on the behalf of some practitioners to utilize exposure with 
older clients and increase the availability of this quick and 
consistently effective technique to all age groups.
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